PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMED vs. EW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GMED and EW is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

GMED vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

250.00%300.00%350.00%400.00%450.00%500.00%550.00%600.00%NovemberDecember2025FebruaryMarchApril
443.63%
325.60%
GMED
EW

Key characteristics

Sharpe Ratio

GMED:

1.13

EW:

-0.62

Sortino Ratio

GMED:

2.10

EW:

-0.55

Omega Ratio

GMED:

1.27

EW:

0.89

Calmar Ratio

GMED:

0.90

EW:

-0.46

Martin Ratio

GMED:

5.02

EW:

-1.12

Ulcer Index

GMED:

7.34%

EW:

22.16%

Daily Std Dev

GMED:

32.66%

EW:

40.18%

Max Drawdown

GMED:

-47.91%

EW:

-54.32%

Current Drawdown

GMED:

-21.36%

EW:

-45.00%

Fundamentals

Market Cap

GMED:

$10.09B

EW:

$42.10B

EPS

GMED:

$0.75

EW:

$2.34

PE Ratio

GMED:

97.85

EW:

30.71

PEG Ratio

GMED:

1.93

EW:

4.26

Total Revenue (TTM)

GMED:

$1.91B

EW:

$4.13B

Gross Profit (TTM)

GMED:

$1.06B

EW:

$3.27B

EBITDA (TTM)

GMED:

$374.73M

EW:

$1.34B

Returns By Period

In the year-to-date period, GMED achieves a -11.27% return, which is significantly lower than EW's -2.92% return. Over the past 10 years, GMED has underperformed EW with an annualized return of 11.23%, while EW has yielded a comparatively higher 11.89% annualized return.


GMED

YTD

-11.27%

1M

-8.63%

6M

4.25%

1Y

38.13%

5Y*

12.70%

10Y*

11.23%

EW

YTD

-2.92%

1M

0.35%

6M

10.40%

1Y

-23.75%

5Y*

3.14%

10Y*

11.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GMED vs. EW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMED
The Risk-Adjusted Performance Rank of GMED is 8585
Overall Rank
The Sharpe Ratio Rank of GMED is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of GMED is 8686
Sortino Ratio Rank
The Omega Ratio Rank of GMED is 8585
Omega Ratio Rank
The Calmar Ratio Rank of GMED is 8383
Calmar Ratio Rank
The Martin Ratio Rank of GMED is 8686
Martin Ratio Rank

EW
The Risk-Adjusted Performance Rank of EW is 2222
Overall Rank
The Sharpe Ratio Rank of EW is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 2424
Sortino Ratio Rank
The Omega Ratio Rank of EW is 1818
Omega Ratio Rank
The Calmar Ratio Rank of EW is 2424
Calmar Ratio Rank
The Martin Ratio Rank of EW is 2525
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMED vs. EW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GMED, currently valued at 1.13, compared to the broader market-2.00-1.000.001.002.003.00
GMED: 1.13
EW: -0.62
The chart of Sortino ratio for GMED, currently valued at 2.10, compared to the broader market-6.00-4.00-2.000.002.004.00
GMED: 2.10
EW: -0.55
The chart of Omega ratio for GMED, currently valued at 1.27, compared to the broader market0.501.001.502.00
GMED: 1.27
EW: 0.89
The chart of Calmar ratio for GMED, currently valued at 0.90, compared to the broader market0.001.002.003.004.005.00
GMED: 0.90
EW: -0.46
The chart of Martin ratio for GMED, currently valued at 5.02, compared to the broader market-5.000.005.0010.0015.0020.00
GMED: 5.02
EW: -1.12

The current GMED Sharpe Ratio is 1.13, which is higher than the EW Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of GMED and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
1.13
-0.62
GMED
EW

Dividends

GMED vs. EW - Dividend Comparison

Neither GMED nor EW has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GMED vs. EW - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum EW drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for GMED and EW. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-21.36%
-45.00%
GMED
EW

Volatility

GMED vs. EW - Volatility Comparison

Globus Medical, Inc. (GMED) has a higher volatility of 9.09% compared to Edwards Lifesciences Corporation (EW) at 5.98%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%NovemberDecember2025FebruaryMarchApril
9.09%
5.98%
GMED
EW

Financials

GMED vs. EW - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab